Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fighting in a wasteland: deleterious metabolites and antitumor immunity
McLane J. Watson, Greg M. Delgoffe
Journal of Clinical Investigation (2022) Vol. 132, Iss. 2
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 251
Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 145
PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy
Xuefeng Dou, Qiang Fu, Qilai Long, et al.
Nature Metabolism (2023) Vol. 5, Iss. 11, pp. 1887-1910
Open Access | Times Cited: 64
Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications
Xianbo Wu, Yuqing Li, Mei Wen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 5, pp. 2643-2692
Closed Access | Times Cited: 33
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion
Xuemei Gu, Haoran Wei, Caixia Suo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer
Bingyu Wang, Zhonghao Mao, Jinwen Ye, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 4, pp. 723-736
Open Access | Times Cited: 9
Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality
Jeremy P. Gygi, Cole Maguire, Ravi K. Patel, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 9
Open Access | Times Cited: 9
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
Yue Zheng, Yiran Yao, Tongxin Ge, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 20
Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy – obstacles and perspectives
Jiřina Procházková, Zuzana Kahounová, Jan Vondráček, et al.
Transcription (2024), pp. 1-20
Closed Access | Times Cited: 5
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 5
Advances in and prospects of immunotherapy for prostate cancer
Deng Liu, Luofu Wang, Yanli Guo
Cancer Letters (2024) Vol. 601, pp. 217155-217155
Open Access | Times Cited: 5
Diabetes can impact cellular immunity in solid tumors
Malgorzata Garstka, Łukasz Kedzierski, Tomasz Maj
Trends in Immunology (2025)
Open Access
Myeloid-derived suppressor cells impair CD4+ T cell responses during chronic Staphylococcus aureus infection via lactate metabolism
Oliver Goldmann, Eva Medina
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 8
Open Access | Times Cited: 11
CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer
Mariusz Shrestha, Dong‐Yu Wang, Yaacov Ben‐David, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Mitochondria in cancer: clean windmills or stressed tinkerers?
Dario C. Altieri
Trends in Cell Biology (2022) Vol. 33, Iss. 4, pp. 293-299
Open Access | Times Cited: 15
Multidimensional profiling of functionalized photothermal nanoplatforms for synergistic cancer immunotherapy: Design, strategy, and challenge
Wei Xiao, Mingzhu Song, Guanghao Jin, et al.
Coordination Chemistry Reviews (2023) Vol. 499, pp. 215488-215488
Closed Access | Times Cited: 8
Nanomodulators targeting tumor-resident immunosuppressive cells: Mechanisms and recent updates
Xinyuan Shen, Chaojie Zhu, Qing Wu, et al.
Nano Today (2022) Vol. 47, pp. 101641-101641
Closed Access | Times Cited: 12
Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models
Nia G. Hammond, Robert B. Cameron, Brandon Faubert
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 2
Photothermal‐Enhanced Dual Inhibition of Lactate/Kynurenine Metabolism for Promoting Tumor Immunotherapy
Yulin Xie, Man Wang, Luying Qiao, et al.
Small Methods (2023) Vol. 8, Iss. 3
Closed Access | Times Cited: 6
Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer
Yong Jae Jin, Ying Xia, Hong Du, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 689, pp. 149188-149188
Closed Access | Times Cited: 6
Proton pump inhibitors display anti‐tumour potential in glioma
Bihan Li, Ying Liu, Shilong Sun
Cell Proliferation (2022) Vol. 56, Iss. 7
Open Access | Times Cited: 10
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
Jeremy P. Gygi, Cole Maguire, Ravi K. Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Immune Escape Mechanism of Cancer
Ayşe Caner
Current Molecular Biology Reports (2023) Vol. 10, Iss. 1, pp. 9-19
Closed Access | Times Cited: 5
Suppression of T cell function by phosphoethanolamine, a metabolite enriched in tumor interstitial fluid
Yupeng Wang, Drew Wilfahrt, Chufan Cai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top